enVVeno Medical Corporation (NASDAQ: NVNO)
$6.08
-0.1100 ( -1.78% ) 78.1K
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
Market Data
Open
$6.08
Previous close
$6.19
Volume
78.1K
Market cap
$80.78M
Day range
$6.02 - $6.42
52 week range
$2.98 - $6.97
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Dec 07, 2023 |
| 4 | Insider transactions | 1 | Dec 07, 2023 |
| 4 | Insider transactions | 1 | Dec 07, 2023 |
| 8-k | 8K-related | 12 | Dec 07, 2023 |
| 8-k | 8K-related | 14 | Nov 16, 2023 |
| def | Proxies and info statements | 5 | Nov 03, 2023 |
| 10-q | Quarterly Reports | 45 | Oct 26, 2023 |
| 8-k | 8K-related | 30 | Oct 12, 2023 |
| 10-q | Quarterly Reports | 42 | Jul 31, 2023 |